Kjerulf, D. G., Wang, S., Omer, M., Pathak, A., Subramanian, S., Han, C. Y., . . . Chait, A. (2020). Glycation of HDL blunts its anti-inflammatory and cholesterol efflux capacities in vitro, but has no effect in poorly controlled type 1 diabetes subjects. J Diabetes Complications.
Chicago Style CitationKjerulf, Diego Gomes, et al. "Glycation of HDL Blunts Its Anti-inflammatory and Cholesterol Efflux Capacities in Vitro, but Has No Effect in Poorly Controlled Type 1 Diabetes Subjects." J Diabetes Complications 2020.
Cita MLAKjerulf, Diego Gomes, et al. "Glycation of HDL Blunts Its Anti-inflammatory and Cholesterol Efflux Capacities in Vitro, but Has No Effect in Poorly Controlled Type 1 Diabetes Subjects." J Diabetes Complications 2020.